RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+8.21%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$337M
AUM Growth
+$337M
(+2.7%)
Cap. Flow
-$4.96M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
34.36%
Holding
108
New
18
Increased
35
Reduced
37
Closed
12
Top Buys
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$11.4M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$9.62M |
| 3 |
Cardinal Health
CAH
|
$6.79M |
| 4 |
AGN
Allergan plc
AGN
|
$5.58M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$3.73M |
Top Sells
| 1 |
Pfizer
PFE
|
$11.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$9.4M |
| 3 |
Gilead Sciences
GILD
|
$5.7M |
| 4 |
CFNL
Cardinal Financial Corp
CFNL
|
$5.03M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
$4.44M |
Sector Composition
| 1 | Healthcare | 85% |
| 2 | Financials | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
AbbVie
ABBV
$374B
| – | – |
-85,494
| Closed | -$4.39M |
|
102
Baxter International
BAX
$12.1B
| – | – |
-42,169
| Closed | -$1.98M |
|
103
Becton Dickinson
BDX
$54.3B
| – | – |
-24,000
| Closed | -$1.59M |
|
104
Cardiff Oncology
CRDF
$130M
| – | – |
-196,537
| Closed | -$1.13M |
|
105
Johnson & Johnson
JNJ
$429B
| – | – |
-19,481
| Closed | -$1.91M |
|
106
Medtronic
MDT
$118B
| – | – |
-39,429
| Closed | -$2.43M |
|
|
FRX
107
DELISTED
FOREST LABORATORIES INC
FRX
| – | – |
-48,152
| Closed | -$4.44M |
|